Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 20, 2012

Treating Relapsing Multiple Sclerosis

  • Multiple Sclerosis
    /
Source: WebMD By Peter Jaret Reviewed By Neil Lava, MD Living with multiple sclerosis means living with uncertainty. The course of…
Multiple Sclerosis

April 20, 2012

The Progression of Multiple Sclerosis

  • Multiple Sclerosis
    /
WebMD Medical Reference Reviewed By Neil Lava, MD How Does the Disease Progress? The course of multiple sclerosis varies for…
Multiple Sclerosis

April 20, 2012

Early Use of MS Drug May Cut Likelihood of Progression

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
THURSDAY, April 19 (HealthDay News) — A new three-year study finds that a multiple sclerosis drug is more likely to…
MS Drug Therapies

April 20, 2012

Novartis adds details on heart safety and monitoring to label of its MS drug Gilenya

  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
April 20, 2012  NEW YORK (AP) — Swiss drugmaker Novartis AG said Friday it is updating the label on its…
Multiple Sclerosis

April 20, 2012

Full CARE-MS II Results for Alemtuzumab to Be Unveiled

  • Misc. Research Reports
    /
  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
PRESS RELEASE April 20, 2012, 1:00 a.m. EDT Genzyme Demonstrates Depth of MS Pipeline at AAN with Results from Multiple…
Misc. Research Reports

April 20, 2012

ASPARTAME and MULTIPLE SCLEROSIS

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
  • Vitamins and Supplements
    /
By Allen Bowling – MD ON 04.27.11 • IN CAM • BY BOWLING • Many have suggested that aspartame, an artificial sweetener often used…
Additional MS resource sites

April 19, 2012

Opexa to Hold Preliminary Investigator’s Meeting for MS Trial at American Academy of Neurology Annual Meeting

  • Misc. Research Reports
    /
  • MS Drug Therapies
    /
THE WOODLANDS, Texas–(BUSINESS WIRE)–Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis…
Misc. Research Reports

April 19, 2012

Webcast on : MS Fatigue: Management Strategies

  • Additional MS resource sites
    /
  • Symptoms
    /
The National MS Society and MS Learn Online invite you to view..        MS Fatigue and  MS Fatigue: Management Strategies …
Additional MS resource sites

April 19, 2012

Clinical trial launches to see whether vitamin D helps treat multiple sclerosis

  • Multiple Sclerosis
    /
  • National MS Society Related
    /
  • Vitamins and Supplements
    /
Thursday – April 19, 2012 The investigator-initiated study, funded by the National MS Society, tests whether supplements added to standard…
Multiple Sclerosis

April 18, 2012

The Benefits of Physical and Social Activity

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
The importance of filling your life with the activities and people you value Remaining active and engaged in life can…
Additional MS resource sites

Categories

Latest Blog Posts